Find clinical trials in your area

Search by disease and location to discover available clinical trials matching your criteria.

Matched clinical trials

  • Study of Fulvestrant and Samuraciclib for Patients with Advanced HR Positive, HER2-Negative Breast Cancer

    Not recruiting

    2 1 1 1
    Investigated drugs:
    Hungary Spain
  • Study on the Effects of Samuraciclib and Elacestrant for Patients with Hormone Receptor-Positive, HER2-Negative Breast Cancer

    Not recruiting

    1 1 1 1
    Investigated diseases:
    Investigated drugs:
    France Spain
  • Study of Pembrolizumab and Chemotherapy for Patients with HR+/HER2- Advanced Breast Cancer

    Not recruiting

    3 1 1
    Austria France Germany Greece Hungary Ireland +7
  • Study on Abemaciclib with Endocrine Therapy for Patients with HR+/HER2- Early Breast Cancer at Intermediate to High Risk

    Not recruiting

    3 1 1 1
    Investigated drugs:
    Germany Poland Spain
  • Study on Gallium (68Ga) Tezatabep Matraxetan PET for Evaluating HER2 Status in Patients with Gastro-Esophageal and HER2-Low Breast Cancer

    Not recruiting

    2 1 1
    Investigated diseases:
    Sweden
  • Study on Ribociclib with Hormone Therapy and Radiotherapy for Elderly Patients with Newly Diagnosed Breast Cancer with Positive Hormone Receptors and Negative HER2 Status

    Not recruiting

    1 1 1 1
    Investigated diseases:
    Investigated drugs:
    France
  • Study Comparing ARV-471 and Fulvestrant for Patients with Advanced Estrogen Receptor-Positive, HER2-Negative Breast Cancer After Endocrine Treatment

    Not recruiting

    3 1 1 1
    Austria Belgium Bulgaria Czechia Finland France +9
  • Comparing inavolisib plus fulvestrant versus alpelisib plus fulvestrant in patients with advanced hormone receptor-positive, HER2-negative breast cancer with PIK3CA mutation

    Not recruiting

    3 1 1 1
    Belgium France Germany Italy Poland Spain
  • Study on the Safety and Antitumor Effects of Vepdegestrant and Abemaciclib in Adults with ER+ Advanced or Metastatic Breast Cancer

    Not recruiting

    1 1 1 1
    Italy Spain
  • Study on the Safety and Antitumor Activity of ARV-471 and Ribociclib in Adults with ER+ Advanced or Metastatic Breast Cancer

    Not recruiting

    1 1 1 1
    Italy Spain